Brain sciences
Centrally Acting Skeletal Muscle Relaxants Sharing Molecular Targets with Drugs for Neuropathic Pain Management.
Judit Mária Kirchlechner-Farkas, David Arpad Karadi, Imre Boldizsár, Nariman Essmat, Anna Rita Galambos, Zoltán Patrik Lincmajer, Sarah Kadhim Abbood, Kornél Király, Éva Szökő, Tamás Tábi, Mahmoud Al-Khrasani
Published: 202510.3390/brainsci16010067
Abstract
Treatment of neuropathic pain (NP) remains a challenge in clinical practice because the current treatment approaches produce satisfactory pain alleviation in only 30% of patients. This necessitates developing novel drugs or repurposing existing medic…
Preview only. Read the full abstract at the source